Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 10391 Records) |
| Query Trace: Breast cancer[original query] |
|---|
| High Expression of ZNF208 Predicts Better Prognosis and Suppresses the Tumorigenesis of Breast Cancer. Clinical Medicine Insights. Oncology 2024 12 18 11795549241301341. Jing Wei, Fangzheng Jiao, Xiaoya Wang, Yifan Qiao, Zihan Yuan, Fang Liu, Yan Fang, Yanfang P |
| Assessment of plasma resolvin levels in women with breast cancer and their associations with disease presentation and immunohistochemical characteristics. Lipids in health and disease 2024 11 23 (1): 396. Alessio Molfino, Giovanni Imbimbo, Gerardo Salerno, Luana Lionetto, Alessandro De Luca, Maria Ludovica Costanzo, Maurizio Simmaco, Maurizio Muscaritoli, Maria Ida Amabi |
| Investigation and validation of neurotransmitter receptor-related biomarkers for forecasting clinical outcomes and immunotherapeutic efficacy in breast cancer. Gene 2024 11 937 149135. Yili Li, Han G |
| The TRIM37 variant rs57141087 contributes to triple-negative breast cancer outcomes in Black women. EMBO reports 2024 11 . Rachisan Djiake Tihagam, Song Lou, Yuanji Zhao, Kammi Song-Yan Liu, Arjun Tushir Singh, Bon Il Koo, Piotr Przanowski, Jie Li, Xiaosong Huang, Hong Li, Jogender Tushir-Singh, Laura Fejerman, Sanchita Bhatnag |
| Targeted Sequencing of HER2-Positive Breast Cancer Mutations Revealed a Potential Association between PIK3CA and Trastuzumab Resistance. Asian Pacific journal of cancer prevention : APJCP 2024 11 25 (11): 4051-4059. Asmaa Mohamed Mekhamer, Marwa Hanafi Saied, Dalia Abd Elmoaty Elneily, Tarek Abdel Halim El-Fayoumi, Doaa Ibrahim Hash |
| Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age-a systematic review. Frontiers in global women's health 2024 11 5 1487820. Shayesteh Jahanfar, Julie Mortazavi, Amy Lapidow, Cassandra Cu, Jude Al Abosy, Kathyrn Morris, Juan Camilo Becerra-Mateus, Meredith Steinfeldt, Olivia Maurer, Jiang Bohang, Paola Andrenacci, Marwa Badawy, Moazzam A |
| DEPTH2 score was associated with cell proliferation and immune cell infiltrations but not with systemic treatment response in breast cancer. Research square 2024 11 . Kohei Chida, Rongrong Wu, Arya Mariam Roy, Takashi Ishikawa, Kenichi Hakamada, Kazuaki Taka |
| The 14-bp insertion/deletion as a promising gene polymorphism to understand cancer risk: Evidence from a systematic review and comprehensive meta-analysis. Heliyon 2024 11 10 (22): e39740. Kalthoum Tizaoui, Mohamed Ali Ayadi, Ines Zemni, Abdel Halim Harrath, Roberta Rizzo, Nadia Boujelbene, Inès Zi |
| Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response. Breast cancer research : BCR 2024 11 26 (1): 170. Parastoo Shahrouzi, Youness Azimzade, Wioletta Brankiewicz-Kopcinska, Sugandha Bhatia, David Kunke, Derek Richard, Xavier Tekpli, Vessela N Kristensen, Pascal H G Dui |
| GFPrint™: A machine learning tool for transforming genetic data into clinical insights. PloS one 2024 11 19 (11): e0311370. Guillermo Sanz-Martín, Daniela Paula Migliore, Pablo Gómez Del Campo, José Del Castillo-Izquierdo, Juan Manuel Domíngu |
| Rare germline variants in cancer-relevant genes are associated with breast cancer risk in young women with high-risk family history. Breast cancer research and treatment 2024 11 . Mariya Rozenblit, Tao Qing, Yixuan Ye, Hongyu Zhao, Erin Hofstatter, Vinit Singh, Emily Reisenbichler, Michael Murray, Lajos Puszt |
| DNMT1 rs2228611, rs2228612 and DNMT3A rs2276598, rs752208 Polymorphisms and Their Association with Breast Cancer Phenotype and Prognosis. Medicina (Kaunas, Lithuania) 2024 11 60 (11): . Meda Marija Kaušylait?, Justina Jurevi??, Erika Korobeinikova, Jurgita Gudaitien?, Elona Juozaityt?, Rasa Ugenskie |
| Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. Cancers 2024 11 16 (22): . Joan Llach, Irina Luzko, Julie Earl, Emma Barreto, Mercedes Rodríguez-Garrote, Marc Lleixà, Cristina Herrera-Pariente, Guerau Fernández, Jenifer Munoz, Laia Bonjoch, Tamara Saurí, Fabio Ausania, Teresa Ocaña, Lorena Moreno, Elia Grau, Josep Oriola, Maria Isabel Alvarez-Mora, Marta Herreros-Villanueva, Sergi Castellví-Bel, Francesc Balaguer, Luis Bujanda, Leticia Morei |
| Immune landscape of the tumour microenvironment in Ethiopian breast cancer patients. Breast cancer research : BCR 2024 11 26 (1): 162. Meron Yohannes, Zelalem Desalegn, Marcus Bauer, Kathrin Stückrath, Endale Anberbir, Yonas Bekuretsion, Mathewos Assefa, Tariku Wakuma, Yasin Worku, Pablo S C Santos, Lesley Taylor, Adamu Adissie, Claudia Wickenhauser, Chiara Massa, Martina Vetter, Eva Johanna Kantelhardt, Barbara Seliger, Tamrat Abe |
| Germline Variant Spectrum in Southern Italian High-Risk Hereditary Breast Cancer Patients: Insights from Multi-Gene Panel Testing. Current issues in molecular biology 2024 11 46 (11): 13003-13020. Valentina Rocca, Elisa Lo Feudo, Francesca Dinatolo, Serena Marianna Lavano, Anna Bilotta, Rosario Amato, Lucia D'Antona, Francesco Trapasso, Francesco Baudi, Emma Colao, Nicola Perrotti, Francesco Paduano, Rodolfo Iulia |
| Pattern Anlysis of Risk-Reducing Strategies in Unaffected Korean BRCA1/2 Mutation Carriers. Current oncology (Toronto, Ont.) 2024 11 31 (11): 6767-6777. Dabin Kim, Jai Min Ryu, Sang-Ah Han, Zisun Kim, Sung-Won K |
| Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer. Current oncology (Toronto, Ont.) 2024 11 31 (11): 6723-6734. Takuma Hayashi, Kenji Sano, Mako Okada, Manabu Muto, Ikuo Konis |
| Association Between the rs13306703 and rs8192288 Variants of the SOD3 Gene and Breast Cancer and an In Silico Analysis of the Variants' Impact. Diseases (Basel, Switzerland) 2024 11 12 (11): . Martha Patricia Gallegos-Arreola, Asbiel Felipe Garibaldi-Ríos, María Teresa Magaña-Torres, Luis E Figuera, Belinda Claudia Gómez-Meda, Guillermo Moisés Zúñiga-González, Ana María Puebla-Pérez, Irving Alejandro Carrillo-Dávila, Mónica Alejandra Rosales-Reynoso, Ingrid Patricia Dávalos-Rodríguez, Jorge I Delgado-Saucedo, Marco Uriel López-Monr |
| Unfavorable Prognostic Impact of HER2 2+/FISH-Negativity in Older Patients with HER2-Negative and High-Risk Breast Cancer. Breast cancer (Dove Medical Press) 2024 11 16 785-793. Hao Wang, Miao Yu, Meihua Chen, Hui Li, Shiwei L |
| Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markers. Breast cancer research and treatment 2024 11 . Dorothea Hanf, Peter Fasching, Paul Gass, Matthias W Beckmann, Carolin C Hack, Felix Heindl, Lothar Häberle, Nelson John, Ramona Erber, Michael F Press, Matthias Rübner, Patrik Pösch |
| Childhood, adolescent and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers. Journal of the National Cancer Institute 2024 11 . Shuai Li, Laura Madanat-Harjuoja, Goska Leslie, Daniel R Barnes, Manjeet K Bolla, Joe Dennis, Michael T Parsons, Paraskevi Apostolou, Norbert Arnold, Kristin Bosse, Antonis C Antoniou On Behalf Of Embrace Collaborators, Jackie Cook, Christoph Engel, D Gareth Evans, Florentia Fostira, Megan N Frone, Andrea Gehrig, Mark H Greene, Karl Hackmann, Eric Hahnen, Nadia Harbeck, Jan Hauke, Julia Hentschel, Judit Horvath, Louise Izatt, Marion Kiechle, Irene Konstantopoulou, Fiona Lalloo, Joanne Ngeow Yuen Yie, Dieter Niederacher, Julia Ritter, Marta Santamariña, Rita K Schmutzler, Claire Searle, Christian Sutter, Marc Tischkowitz, Vishakha Tripathi, Ana Vega, Hannah Wallaschek, Shan Wang-Gohrke, Barbara Wappenschmidt, Bernhard H F Weber, Drakoulis Yannoukakos, Emily Zhao, Douglas F Easton, Antonis C Antoniou, Georgia Chenevix-Trench, Timothy R Rebbeck, Lisa R Dill |
| The impact of pathogenic BRCA1/2 tumor mutation status on high grade serous epithelial ovarian cancer survival outcome: A multicenter study from Indonesia. SAGE open medicine 2024 11 12 20503121241299849. Sutrisno Sutrisno, Dina Marlina, Kevin Dominique Tjandraprawira, Putri Nadhira Adinda Adriansy |
| The functional TNF-?G?>?a single-nucleotide polymorphism (rs1800629): association with the predictive indices of breast cancer carcinogenesis. Breast cancer research and treatment 2024 11 . Sherif Refaat, Hanan E Al-Rashidi, Rania A Abd El Azeem, Walaa E Nouh, Sahar Hamed, Zeinab R Att |
| Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations. Nature genetics 2024 11 . Marc J Williams, Michael U J Oliphant, Vinci Au, Cathy Liu, Caroline Baril, Ciara O'Flanagan, Daniel Lai, Sean Beatty, Michael Van Vliet, Jacky Ch Yiu, Lauren O'Connor, Walter L Goh, Alicia Pollaci, Adam C Weiner, Diljot Grewal, Andrew McPherson, Klarisa Norton, McKenna Moore, Vikas Prabhakar, Shailesh Agarwal, Judy E Garber, Deborah A Dillon, Sohrab P Shah, Joan S Brugge, Samuel Aparic |
| A Novel HLA-A*24 Variant, HLA-A*24:02:01:144Q, Identified in a Breast Cancer Patient From Brazil. HLA 2024 11 104 (5): e15761. Vinícius N Stelet, Christina Silva, Matilde Romero, Renata Binato, Eliana Abdelh |
| Impact of cytotoxic therapy on clonal hematopoiesis and myeloid neoplasms in breast cancer patients. Medicine 2024 11 103 (46): e40540. Heyjin Kim, Hyeon-Ok Jin, Ji-Young Kim, Young Jun Hong, Jin Kyung L |
| Exploration of BRCA1 and BRCA2 mutations in gastric cancer patients through next generation sequencing: implications for diagnosis and therapy. American journal of translational research 2024 11 16 (10): 5357-5370. Ishtiaq Ahmed, Sania Anwar, Muhammad Aitzaz Akram, Usman Zeb, Alok Bharadwaj, Rabeea Zia, Muhammad Asadullah Usman, Saeedah Musaed Almutairi, Dunia A Al Farraj, Nada H Aljarba, Mariam Abdulaziz Alkhateeb, Amirah Fahad Alshamme |
| Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome. JCO global oncology 2024 11 10 e2400352. Rifaat R Rawashdeh, Holly Pederson, Rafal Iskanderian, Fawad Khan, Basel Altrabulsi, Stephanie Ricci, Charis Eng, Bassel Jallad, Asma Ibrahim Al Mannaei, Mohamed Salem Alameri, Azza Attia, Stephen R Grobmy |
| CYP2D6 Phenotype and Breast Cancer Outcomes: A Bias Analysis and Meta-Analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2024 11 OF1-OF10. Richard F MacLehose, Thomas P Ahern, Lindsay J Collin, Aixin Li, Timothy L La |
| Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients. Genome medicine 2024 11 16 (1): 131. Xiuli Zhang, S Peter Goedegebuure, Michael Y Chen, Rashmi Mishra, Felicia Zhang, Yik Yeung Yu, Kartik Singhal, Lijin Li, Feng Gao, Nancy B Myers, Tammi Vickery, Jasreet Hundal, Michael D McLellan, Mark A Sturmoski, Samuel W Kim, Ina Chen, Jesse T Davidson, Narendra V Sankpal, Stephanie Myles, Rama Suresh, Cynthia X Ma, Ademuyiwa Foluso, Andrea Wang-Gillam, Sherri Davies, Ian S Hagemann, Elaine R Mardis, Obi Griffith, Malachi Griffith, Christopher A Miller, Ted H Hansen, Timothy P Fleming, Robert D Schreiber, William E Gillande |
- Page last reviewed:Feb 1, 2024
- Content source: